In Brief: Tagamet HB ad
This article was originally published in The Tan Sheet
Executive Summary
Tagamet HB ad: TV advertising that began April 13 touts Tagament HB as the only OTC H2 antagonist to be approved "in a full prescription strength" and for being at the "same strength doctors have prescribed to safely treat heartburn for over 15 years." The ad also claims that "nothing stops stomach acid faster." The campaign is being handled by Ogilvy & Mather. Tagamet HB is approved in 200 mg doses up to twice daily. The lowest Rx dose for Tagamet -- 400 mg -- is approved for maintenance therapy in patients with duodenal ulcers...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning